SCHEMBL9131313

SCHEMBL9131313

O=C1c2ccccc2S(O)(O)N1CCCN1CCC(Oc2ccc3ccccc3c2)C1

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 5/20 0.42
▸ CHRM2 P08172 1/20 0.41
▸ CHRM3 P20309 1/20 0.41
▸ ADRA1D P25100 2/20 0.40
▸ ADRA1A P35348 2/20 0.40
▸ ADRA1B P35368 2/20 0.40
▸ DRD2 P14416 3/20 0.39
▸ HRH3 Q9Y5N1 4/20 0.39
▸ HTR2A P28223 2/20 0.38
▸ HTR7 P34969 2/20 0.38
▸ HTR6 P50406 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9134839 0.98 ADRA1D (0.42) HTR1ACHRM2CHRM3ADRA1DADRA1A
SCHEMBL9132145 0.97 HTR1A (0.42) HTR1ACHRM2CHRM3ADRA1DADRA1A
SCHEMBL9130405 0.94 HTR2A (0.38) CHRM2CHRM3HTR2AHTR7
SCHEMBL9131309 0.90 HTR1A (0.51) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL9134836 0.89 DRD2 (0.52) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL9132141 0.88 DRD2 (0.53) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL9129907 0.87 HTR1A (0.50) HTR1ACHRM2CHRM3ADRA1DADRA1A
SCHEMBL9131296 0.87 HTR1A (0.51) HTR1ACHRM2CHRM3ADRA1DADRA1A
SCHEMBL9129953 0.85 HTR1A (0.52) HTR1ACHRM2CHRM3ADRA1DADRA1A
SCHEMBL9129940 0.85 HTR2A (0.40) HTR1AADRA1DADRA1AADRA1BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5453437-A 1,3-disubstituted pyrrolidines BAYER AKTIENGESELLSCHAFT (DE) 1995-09-26 — — US disclosed
US-5274097-A A 1-N-heterocyclic alkylene-3-carbo or heterocyclic ring oxypyrrolidine derivative BAYER AKTIENGESELLSCHAFT (DE) 1993-12-28 — — US disclosed
US-5037841-A For treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1991-08-06 — — US disclosed
Send feedback